Generic drugs saved the U.S. healthcare system $3.4 trillion from 2015-2024. Learn how Hatch-Waxman, biosimilars, and market competition drive these massive savings and what challenges remain.
Aug, 26 2025
Dec, 15 2025
Feb, 28 2025
Feb, 21 2025
Jan, 20 2026